Skip to main content

Table 1 Characteristics of patients in burst suppression and non-burst suppression groups

From: Does burst-suppression achieve seizure control in refractory status epilepticus?

Variable

Burst suppression group

Non-burst suppression group

P-valueb

n (%)

n (%)

Age (years)

  

0.136

 < 30

5 (19.2)

8 (32.0)

 

 30–60

9 (34.6)

12 (48.0)

 

 > 60

12 (46.2)

5 (20.0)

 

Sex

  

0.068

 male

16 (61.5)

9 (36.0)

 

 female

10 (38.5)

16 (64.0)

 

Etiology

  

0.353

 encephalitis

13 (50)

10 (40.0)

 

 metabolic

10 (38.5)

8 (32.0)

 

 static lesion

1 (3.8)

5 (20.0)

 

 drug withdrawal

2 (7.7)

2 (8.0)

 

History of epilepsy

  

0.067

 yes

7 (26.9)

13 (52.0)

 

 no

19 (73.1)

12 (48.0)

 

Number of antiepileptic drugs (before midazolam therapy)

  

0.35

 2

10 (38.5)

5 (20.0)

 

 3

11 (42.3)

14 (56.0)

 

 4

5 (19.2)

6 (24.0)

 

Status epilepticus severity score

  

0.27

 3

7 (29.9)

12 (48.0)

 

 4

15 (57.7)

11 (44.0)

 

  > 4

4 (15.4)

2 (8.0)

 

Dose of midazolam (mg/kg/day)

  

0.350

  < 0.6

10 (38.5)

5 (20.0)

 

 0.6–1.2

11 (42.3)

14 (56.0)

 

  > 1.2

5 (19.2)

6 (24.0)

 

Time to midazolam therapy (hours)

  

0.676

  ≤ 24

14 (53.8)

12 (48.0)

 

  > 24

12 (46.2)

13 (52.0)

 

Length of hospital stay (days)

  

0.747

  < 14

11 (42.3)

8 (32.0)

 

 14–21

9 (34.6)

10 (40.0)

 

  > 21

6 (23.1)

7 (28.0)

 

Breakthrough seizure

  

< 0.001

 no

19 (73.1)

1 (4.0)

 

 yes

7 (26.9)

24 (96.0)

 

Withdrawal seizure

  

0.061

 no

12 (46.2)

18 (72.0)

 

 yes

14 (53.8)

7 (28.0)

 

Pulmonary complication

  

0.657

 no

14 (53.8)

15 (60.0)

 

 yes

12 (46.2)

10 (40.0)

 

Cardiac complication

  

0.789

 no

20 (76.9)

20 (80.0)

 

 yes

6 (23.1)

5 (20.0)

 

Fever/infection

  

0.301

 no

14 (53.8%)

17 (68%)

 

 yes

12 (46.2%)

8 (32%)

 

In-hospital mortality

  

0.029

 alive

12 (46.2)

19 (76.0)

 

 dead

14 (53.8)

6 (24.0)

 

Functional outcome at 3 monthsa

  

0.379

 good

7 (58.3)

8 (42.1)

 

 poor

5 (41.7)

11 (57.9)

 
  1. aexcluding dead patients
  2. bChi-square test